Form 8.3 - [Allergan Plc]
March 20 2020 - 11:17AM
Dow Jones News
TIDM0Y7T TIDM0QCV
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in Allergan plc
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.0001 ordinary shares
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 19(th) March 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 13,632,032 4.14131%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 13,632,032 4.14131%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 300 171.26
-------------- ----------------------------- -----------------------
Purchase 100 171.26
-------------- ----------------------------- -----------------------
Purchase 400 171.26
-------------- ----------------------------- -----------------------
Purchase 100 171.26
-------------- ----------------------------- -----------------------
Purchase 300 171.26
-------------- ----------------------------- -----------------------
Purchase 443 171.26
-------------- ----------------------------- -----------------------
Purchase 138 171.26
-------------- ----------------------------- -----------------------
Purchase 736 171.26
-------------- ----------------------------- -----------------------
Purchase 23 171.26
-------------- ----------------------------- -----------------------
Purchase 352 171.26
-------------- ----------------------------- -----------------------
Purchase 88 171.26
-------------- ----------------------------- -----------------------
Purchase 120 171.26
-------------- ----------------------------- -----------------------
Purchase 126 171.26
-------------- ----------------------------- -----------------------
Sale 200 168.88
-------------- ----------------------------- -----------------------
Sale 4,500 166.86
-------------- ----------------------------- -----------------------
Sale 800 171.26
-------------- ----------------------------- -----------------------
Sale 300 171.26
-------------- ----------------------------- -----------------------
Sale 300 171.26
-------------- ----------------------------- -----------------------
Sale 1,700 171.26
-------------- ----------------------------- -----------------------
Sale 100 168.35
-------------- ----------------------------- -----------------------
Sale 11,600 171.26
-------------- ----------------------------- -----------------------
Sale 100 171.26
-------------- ----------------------------- -----------------------
Sale 56 166.00
-------------- ----------------------------- -----------------------
Sale 27,974 171.26
-------------- ----------------------------- -----------------------
Sale 38,984 171.26
-------------- ----------------------------- -----------------------
Sale 110 171.26
-------------- ----------------------------- -----------------------
Sale 200 170.85
-------------- ----------------------------- -----------------------
Sale 240 171.26
-------------- ----------------------------- -----------------------
Sale 2900 171.26
-------------- ----------------------------- -----------------------
Sale 400 171.26
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 20(th) March 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 20, 2020 11:02 ET (15:02 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Aug 2024 to Sep 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Sep 2023 to Sep 2024